Resources Contact Us Home
Distribution management method, a distribution management system and a distribution management server

Image Number 18 for United States Patent #7979515.

A distribution management system is provided which can have a high software distribution efficiency by using client terminals substituting for software distribution relay and can reliably collect distribution results without depending upon the statuses of client terminals. A distribution management server groups a plurality of representative clients in charge of software distribution relay, and changes assignment of software distribution target client terminals by monitoring the distribution execution status of each representative client terminal. Further, the client terminal can reliably notify the distribution result to the distribution management server in accordance with a list of grouped representative client terminals. Furthermore, for the client terminal not notifying the distribution result even if the notice term expires, a distribution result notice representative client terminal is set further so that the distribution result can be reliably notified to the distribution management server.

  Recently Added Patents
Hydrothermal synthesis of nanocubes of sillenite type compounds for photovoltaic applications and solar energy conversion of carbon dioxide to fuels
Trash receptacle
Semiconductor device
Targeting agents for enhancing radiation therapy
Sharing networks determined by sharing of items between individuals
Point-in-time copies in a cascade using maps and fdisks
Method and system for filtering noises in an image scanned by charged particles
  Randomly Featured Patents
Pinch valve
Method for coating a substrate using plasma
Line head and image forming device using the same
Decorative plaque
Solid forms of the magnesium salt of S-omeprazole and processes for their preparation
Imaging device
.DELTA..sup.2,3 -1,4 Morpholine-2-carboxylic acid derivatives as antibacterial agents
Image forming apparatus and fixing device
Method for prediction prostate cancer patients' resistance to hormonal treatment by measuring serum concentrations of chromogranin A